RS 2232 is an orally active, competitive 5-HT deamination inhibitor with a K i of 0.054 μM. RS-2232 exhibits reversible and specific inhibition of type A monoamine oxidase . RS 2232 can be used in brain research.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > 5-HT Receptor | Products > Signaling Pathways > Monoamine Oxidase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.